{"id":908875,"date":"2025-11-12T11:10:04","date_gmt":"2025-11-12T16:10:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/"},"modified":"2025-11-12T11:10:04","modified_gmt":"2025-11-12T16:10:04","slug":"io-biotech-announces-participation-in-upcoming-investor-conferences-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/","title":{"rendered":"IO Biotech Announces Participation in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Nov.  12, 2025  (GLOBE NEWSWIRE) &#8212; IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that members of its senior management team will participate in the following upcoming investor conferences:<\/p>\n<p align=\"justify\">Event: Jefferies Global Healthcare Conference<br \/>Location: London<br \/>Presentation: Tuesday, November 18, 2025, at 3:00 PM GMT <br \/>Presenter: Mai-Britt Zocca, PhD, President &amp; CEO<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cILd3TjQtQXnaCOyDqvd52Z-mDK-tW5B2kPWn3h6PvrL60gQQldEXZRd4NNtI6hupauLxaamXSlmpEoC2voxj96pRZSmvf5rBTZqyRgdnoMQyUqcpkQBzCGm2ei7yIuJcxQYlbFwtBwsBIgzoWkTVir4Guo33xLBmo1gJj_Ssl8NNbGwa0l-qYHczaCyeBl0KNA9I49xzdfK2piUOQ4uXonqdLVHcTFqCA-WgIcOsEjhyiTPdYDs9kJJNhFRvv3y0IzTtp3ecFXNuLBCLLKkr9OcjEHKTh1vPR5LbGbuS4Fk1iXYwC3_dl9j1LbvUh7Vv2ymNLwVn96fmZI-lwV7UgznSYqj8JKuiGyRan0y49udEFW30YIKk0ZVKP3LyLVn0dxCq2fTqbBl-E78Hw3SIAvSfqi1Yk-GyspqgUdwyuDaYfjXG2QJUgzp9AO_ykHShuVwm0ZrcccXJaVU9sBAml5A7WQT3tX8HOQ7TqmDh6eQDWV269J9_OWJ9XwosCG4bwg1qENrXjVtBDnRzjmA58y1R4og8YkW5BJb2DdQ9xfH0pe-Zlk1__nYhYuLAaE5VLQkohEgo9zsn7vbMwCq1XECFokdlt_Px9i9BGLvl5MmcJaJqz_nOOskCQX-dmv6qTIb-fBsCXH7u32agg3JtPs6G4_fPo3RP2uwK9CGt_Wq_pXtZw0g4njccBTbLBqh\" rel=\"nofollow\" target=\"_blank\">https:\/\/wsw.com\/webcast\/jeff332\/iobt\/1846538<\/a><\/p>\n<p align=\"justify\">Event: Piper Sandler 36<sup>th<\/sup> Annual Healthcare Conference<br \/>Location: New York<br \/>Fireside chat: Wednesday, December 3, 2025, at 3:00 pm ET<br \/>Presenter: Mai-Britt Zocca, PhD, President &amp; CEO<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cILd3TjQtQXnaCOyDqvd51n7IA6HQ8s0-IouZzXzXdGprK_y59SpK1C9KgukTr-e3LaC9ETdYz51IbLDrshBIOexagq5juracqmMZHFUg7a-Jtnt5drepVqukv8uxO5H3k6xccQ576xGGEneYf3kwzEFKkPyBhYe3qrNzDMCngxyHnbPwSvcaIVABRkXVh0BF3CcTZ8mZLq1aq33WSBoiwV7gXdkgAgVeDQ7aDZMtI8=\" rel=\"nofollow\" target=\"_blank\">https:\/\/event.webcasts.com\/starthere.jsp?ei=1742757&amp;tp_key=8b79a34402<\/a><\/p>\n<p align=\"justify\">A webcast replay of the Jefferies corporate presentation and Piper fireside chat will be available on IO Biotech\u2019s website at www.iobiotech.com for 90 days following the presentation.<\/p>\n<p align=\"justify\">\n        <strong>About IO Biotech<\/strong>\n      <\/p>\n<p align=\"justify\">IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win\u00ae platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, Cylembio\u00ae, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York.<\/p>\n<p align=\"justify\">For further information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ElU06h9B0fugf7-r_3VPDa9sOI9HCJkYd1IzDoCu7IFMGF-gNE_eELOoMVoPMLSqg07WaL-_cpkr4s3No8MahpK5phw5xduVtnx71w_5IOM=\" rel=\"nofollow\" target=\"_blank\">www.iobiotech.com<\/a>. Follow us on our social media channels on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VLpt3AmEXPlEAE9r7mTqcYx7hCgAevcn6lcxgB5tRCYLXd7DVr_KYBIPxYmpy_D63af6usnnvfpGBiKPCxWiM_yaib3Yyp0UKi8ovnUXpfg=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and X (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BYTGKinUIWrrL2W-g6eaeUp3nj7-q6Pc8dW7Hq0UeHDq3qxUyPBBCYawjCqpYuGCUprPo1CVx-UrRU5BRJNLz6fWs2MYZlx95EGCOhA035Q=\" rel=\"nofollow\" target=\"_blank\">@IOBiotech<\/a>).<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statement<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including statements regarding the timing or outcome of communications with regulatory authorities including the FDA, the timing or outcome of the submission of regulatory applications, including an IND for IO112, and statements regarding other current or future clinical trials, their timing, progress, enrollment or results, or the company\u2019s financial position or cash runway, are based on IO Biotech\u2019s current assumptions and expectations of future events and trends, which affect or may affect its business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date hereof and should not be unduly relied upon. Except to the extent required by law, IO Biotech undertakes no obligation to update these statements, whether as a result of any new information, future developments or otherwise.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Investors and media:<\/strong><br \/>\n        <br \/>Maryann Cimino, Director of Investor Relations &amp; Corporate Communications<br \/>IO Biotech, Inc.<br \/>617-710-7305<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YSLdpZ228Q8ozg7Cb8hGu_MNo7I_U_vAhGtZaWcnQmX672UzB4ac8BUq0cujg3Vse0aJsuJQhagH2p5NzmsO3RdcV0rz6D9bmZ9OOkPvG8k=\" rel=\"nofollow\" target=\"_blank\">mci@iobiotech.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTNiOWQwZjUtYWExZS00YmU3LTk4ZTAtOTdkNzA1YTQ3NDUxLTEyNzMwMzEtMjAyNS0xMS0xMi1lbg==\/tiny\/IO-Biotech.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) &#8212; IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that members of its senior management team will participate in the following upcoming investor conferences: Event: Jefferies Global Healthcare ConferenceLocation: LondonPresentation: Tuesday, November 18, 2025, at 3:00 PM GMT Presenter: Mai-Britt Zocca, PhD, President &amp; CEOWebcast Link: https:\/\/wsw.com\/webcast\/jeff332\/iobt\/1846538 Event: Piper Sandler 36th Annual Healthcare ConferenceLocation: New YorkFireside chat: Wednesday, December 3, 2025, at 3:00 pm ETPresenter: Mai-Britt Zocca, PhD, President &amp; CEOWebcast Link: https:\/\/event.webcasts.com\/starthere.jsp?ei=1742757&amp;tp_key=8b79a34402 A webcast replay of the Jefferies corporate presentation and Piper fireside chat will be available on IO Biotech\u2019s website at www.iobiotech.com for 90 days following the presentation. About IO Biotech IO &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IO Biotech Announces Participation in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-908875","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IO Biotech Announces Participation in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IO Biotech Announces Participation in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) &#8212; IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that members of its senior management team will participate in the following upcoming investor conferences: Event: Jefferies Global Healthcare ConferenceLocation: LondonPresentation: Tuesday, November 18, 2025, at 3:00 PM GMT Presenter: Mai-Britt Zocca, PhD, President &amp; CEOWebcast Link: https:\/\/wsw.com\/webcast\/jeff332\/iobt\/1846538 Event: Piper Sandler 36th Annual Healthcare ConferenceLocation: New YorkFireside chat: Wednesday, December 3, 2025, at 3:00 pm ETPresenter: Mai-Britt Zocca, PhD, President &amp; CEOWebcast Link: https:\/\/event.webcasts.com\/starthere.jsp?ei=1742757&amp;tp_key=8b79a34402 A webcast replay of the Jefferies corporate presentation and Piper fireside chat will be available on IO Biotech\u2019s website at www.iobiotech.com for 90 days following the presentation. About IO Biotech IO &hellip; Continue reading &quot;IO Biotech Announces Participation in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-12T16:10:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IO Biotech Announces Participation in Upcoming Investor Conferences\",\"datePublished\":\"2025-11-12T16:10:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/\"},\"wordCount\":485,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/\",\"name\":\"IO Biotech Announces Participation in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=\",\"datePublished\":\"2025-11-12T16:10:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IO Biotech Announces Participation in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IO Biotech Announces Participation in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/","og_locale":"en_US","og_type":"article","og_title":"IO Biotech Announces Participation in Upcoming Investor Conferences - Market Newsdesk","og_description":"NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) &#8212; IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that members of its senior management team will participate in the following upcoming investor conferences: Event: Jefferies Global Healthcare ConferenceLocation: LondonPresentation: Tuesday, November 18, 2025, at 3:00 PM GMT Presenter: Mai-Britt Zocca, PhD, President &amp; CEOWebcast Link: https:\/\/wsw.com\/webcast\/jeff332\/iobt\/1846538 Event: Piper Sandler 36th Annual Healthcare ConferenceLocation: New YorkFireside chat: Wednesday, December 3, 2025, at 3:00 pm ETPresenter: Mai-Britt Zocca, PhD, President &amp; CEOWebcast Link: https:\/\/event.webcasts.com\/starthere.jsp?ei=1742757&amp;tp_key=8b79a34402 A webcast replay of the Jefferies corporate presentation and Piper fireside chat will be available on IO Biotech\u2019s website at www.iobiotech.com for 90 days following the presentation. About IO Biotech IO &hellip; Continue reading \"IO Biotech Announces Participation in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-12T16:10:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IO Biotech Announces Participation in Upcoming Investor Conferences","datePublished":"2025-11-12T16:10:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/"},"wordCount":485,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/","name":"IO Biotech Announces Participation in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=","datePublished":"2025-11-12T16:10:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3Mzc3MyM3MjU4MDQxIzIyNjE0ODE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/io-biotech-announces-participation-in-upcoming-investor-conferences-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IO Biotech Announces Participation in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=908875"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908875\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=908875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=908875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=908875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}